Ionis Rockets As Biogen-Partnered ALS Drug Wins Key Endorsement

Ionis Rockets As Biogen-Partnered ALS Drug Wins Key Endorsement

Submitted by admin on March 23, 2023 - 9:58am
Source: 
Investors Business Daily
News Tags: 
Ionis Pharmaceuticals
Biogen
ALS
FDA
tofersen
Headline: 
Ionis Rockets As Biogen-Partnered ALS Drug Wins Key Endorsement
snippet: 

Ionis stock jumped Thursday after a Food and Drug Administration panel offered a mixed view of its Biogen (BIIB)-partnered treatment for a deadly neurodegenerative condition.

Do Not Allow Advertisers to Use My Personal information